Your search returned 4 results.

Results
	1.	Cardiac safety of rasagiline, a selective monoamine oxidase type B inhibitor for the treatment of Parkinson's disease: a thorough QT/QTc study. [electronic resource] by Mendzelevski, Boaz Sprenger, Craig R Spiegelstein, Ofer Rabinovich-Guilatt, Laura Producer: 20140527 In: International journal of clinical pharmacology and therapeutics vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes. [electronic resource] by Chatterjee, Dhruba J Khutoryansky, Naum Zdravkovic, Milan Sprenger, Craig R Litwin, Jeffrey S Producer: 20100107 In: Journal of clinical pharmacology vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Extended-duration dosing and distribution of dalbavancin into bone and articular tissue. [electronic resource] by Dunne, Michael W Puttagunta, Sailaja Sprenger, Craig R Rubino, Chris Van Wart, Scott Baldassarre, James Producer: 20151215 In: Antimicrobial agents and chemotherapy vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Effects of injectable HPβCD-diclofenac on the human delayed rectifier potassium channel current in vitro and on proarrhythmic QTc in vivo. [electronic resource] by Carr, Daniel B McDonnell Moorehead, Tara Bouchard, Annie Sprenger, Craig R Hamilton, Douglas A Lang, Eric Madden, Donna Lacouture, Peter G Wright, Curtis Producer: 20131230 In: Clinical therapeutics vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)